Nucleoside Analogs: Similarities and Differences.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S7
- By:
- Publication type:
- Article
Works matching IS 10584838 AND DT 1993 AND VI 16 AND IP Supplement_1
Results: 13
1
2
Tolerability of Combined Ganciclovir and Didanosine for the Treatment of Cytomegalovirus Disease Associated with AIDS.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S69
- By:
- Publication type:
- Article
3
The Didanosine Expanded Access Program: Safety Analysis.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S63
- By:
- Publication type:
- Article
4
Use of Didanosine in Zidovudine-Intolerant Patients Infected with Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S59
- By:
- Publication type:
- Article
5
Didanosine in the Treatment of AIDS and AIDS-Related Complex: A Critical Appraisal of the Dose and Frequency of Administration.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S52
- By:
- Publication type:
- Article
6
Long-Term Follow-Up of Didanosine Administered Orally Twice Daily to Patients with Advanced Human Immunodeficiency Virus Infection and Hematologic Intolerance of Zidovudine.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S46
- By:
- Publication type:
- Article
7
Didanosine: Long-Term Follow-Up of Patients in a Phase 1 Study.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S40
- By:
- Publication type:
- Article
8
Longitudinal Analysis of Responses to Oral Didanosine Therapy Following Zidovudine Therapy in Advanced Infection with Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S32
- By:
- Publication type:
- Article
9
Relation Between Plasma Concentrations of Didanosine and Markers of Antiviral Efficacy in Adults with AIDS or AIDS-Related Complex.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S26
- By:
- Publication type:
- Article
10
Surrogate Markers in AIDS Clinical Trials: Conceptual Basis, Validation, and Uncertainties.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S22
- By:
- Publication type:
- Article
11
The Natural History of HIV Infection: Implications for the Assessment of Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S2
- By:
- Publication type:
- Article
12
In Vitro Antiviral Activity of Didanosine Compared with That of Other Dideoxynucleoside Analogs Against Laboratory Strains and Clinical Isolates of Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S16
- By:
- Publication type:
- Article
13
Introduction.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. Supplement_1, p. S1
- By:
- Publication type:
- Article